May 9, 2023

Global Hepatitis Resource Mobilization Conference 2023 Agenda

This is the current agenda for the Global Hepatitis Resource Mobilization Conference in Geneva, Switzerland on Wednesday, May 17, 2023. The event takes place from 9:00 AM to 4:30 PM CET (GMT+2) at the Hotel Intercontinental in Geneva (Conference Registration Opens at 8:00 AM).

*Please note that this page is continuously being updated as participants and sessions are confirmed, so please check back regularly.

Event Moderator: Jacqui Thornton – Global Health Journalist

9:00 – 9:40 AM – Opening Session

  • Welcome to the conference: Finn-Jarle Rode, Executive Director, The Hepatitis Fund
  • Welcome video message: Dr Chelsea Clinton, Board of Directors, Clinton Health Access Initiative
  • Honorary Guest: Dr Al-Issa, H.E. Secretary General, Muslim World League
  • Opening Remarks: Prof. Michel Kazatchkine, Senior Fellow, Global Health Center, The Graduate Institute for international Affairs and Development, Geneva
  • Video Message: Helen Clark, Chair of the Global Commission on Drug Policy, former Prime Minister of New Zealand, and Global Ambassador of The Hepatitis Fund

9:40 – 10:10 AM – Session One: Supporting Hepatitis Elimination – Hosts And Partners Remarks

  • Chair: Gregg Alton, Chairman Board of Directors, The Hepatitis Fund
  • Rakan Khalid Bin Dohaish, Assistant Deputy Minister for International Collaborations, Ministry of Health, Kingdom of Saudi Arabia
  • Prof Mohamed Hassany, Assistant to the Minister of Health, Arab Republic of Egypt
  • Dr Tedros Adhanom Ghebreyesus, Director General, World Health Organization
  • Dr David Ripin, Executive Vice President, Infectious Diseases; Chief Science Officer, Clinton Health Access Initiative

10:10 – 10:40 AM – Session Two: Call to Action – Voices Of The Community

  • Kenneth Kabagambe – Hepatitis Advocate, Uganda
  • Anton Basenko – Harm Reduction Services and Integrated HIV and Hepatitis Care, Ukraine
  • Raquel Peck – Living and being cured from HCV, England | Brazil
  • Sister Annie Kanunga – Caring for people who live with HBV, Zambia
  • Video message: Joelle Dountio, Acting HCV Project Director, Treatment Action Group

10:40 – 11:10 AM – Session Three: The Case For Hepatitis Elimination – Expert Opinions

  • Chair: Dr Su Wang, People who live with HBV and Medical Director of the Center for Asian Health at Saint Barnabas Medical Center, US
  • Dr Meg Doherty, Director of WHO’s Global HIV, Hepatitis, and Sexually Transmitted Infections Programmes – Viral Hepatitis Elimination, an SDG we can reach
  • Dr Homie Razavi, Managing Director of the Center for Disease Analysis Foundation – The Hepatitis Elimination Investment Case

11:10 – 11:30 AM – Coffee Break

11:30 – 12:45 PM – Session Four: Country Experiences

  • Chair: Oriel Fernandes, Senior Director, Viral Hepatitis, Clinton Health Access Initiative, and Naomi Burke-Shyne, Executive Director, Harm Reduction International
  • Dr Keo Samley, Vice Chief of Bureau Prevention and Control of Communicable Disease Control Department, Ministry of Health, Cambodia
  • Dr Akudo Ikpeazu, National Coordinator, National AIDS, Viral Hepatitis and STIs Control Programme, Federal Ministry of Health, Nigeria.
  • Dr Baseer Khan Achakzai, Director General Health, Ministry of Health, Pakistan
  • Dr Gallican Rwibasira, Head of National HIV, STIs and Hepatitis Programs, Ministry of Health, Rwanda
  • Dr Daniel Kyabayinze, Director of Public Health, Ministry of Health, Uganda
  • Dr Lloyd Mulenga, Director of Infectious Diseases, Ministry of Health, Zambia

12:45 – 1:45 PM – Lunch Break

1:45 – 2:45 PM – Session Five: Access To Diagnostics And Treatment – The Role Of Industry

  • Chair: Dr David Ripin, Executive Vice President, Infectious Diseases; Chief Science Officer, Clinton Health Access Initiative
  • Panel Discussion:
    • Sophia Chao, Lifecycle Leader for Infectious Disease, Roche
    • Dr Francesco Marinucci, Director, Global Market Access & Funding, Molecular Diagnostics, Abbott
    • Tiffany Clarke, Director, Global Health Strategy, Hologic
    • Rachel O’Shea, Vice President for Global Market Access, Cepheid
    • Kedar Madhekar, Associate Vice President – Strategic Initiatives and Commercial Operations, Viatris
    • Rahul Lande, Vice President of Global Access Division, Hetero
    • Charles Gore, Executive Director, Medicines Patent Pool
  • Company Commitments

2:45 – 3:00 PM – Coffee Break

3:00 – 4:20 PM – Session Six: Commitments And Announcements

  • Organizational Investments | Direct Programmatic Commitments:
    • Dr Siobhan Crowley, Global Fund to Fight AIDS, Tuberculosis and Malaria
    • Dr Mohammed Abdulaziz, Africa Centres for Disease Control and Prevention
    • Dr Karin Timmermans, UNITAID
    • Dr George Siberry, USAID
    • Dr Bill Rodriguez, FIND
  • Country Domestic Commitments
    • Dr Emmanuel Akabe, Deputy Governor of Nasarawa State, Nigeria
    • Dr Mario Gonzalez, Coordinator of Viral Hepatitis National Programme, Brazil
    • Dr Baseer Khan Achakzai, Director General Health, Ministry of Health, Pakistan
  • Monetary Pledges to The Hepatitis Fund

4:20 – 4:30 PM – Closing Session

  • Dr Manal El-Sayed, Board of Directors, The Hepatitis Fund
  • Nathalie Fontanet, State Councillor, Head of the Finance Department of the Republic and Canton of Geneva
Back To Top